Certificate under Regulation 74(5) of SEBI (DP) Regulations, 2018 for the quarter ended 30-06-2026.
KPL · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Kwality Pharmaceuticals has submitted a routine compliance certificate to BSE under SEBI Regulation 74(5) for the quarter ended June 30, 2026. The certificate was issued by Bigshare Services Private Limited, the company's Registrar and Share Transfer Agent (RTA). It confirms that all securities received from depository participants for dematerialization during the quarter were properly processed, verified, and the company's name was substituted in the register of members within the required 15-day timeline. This is a standard quarterly filing with no financial or business details disclosed.
This is a routine procedural filing required by SEBI for all listed companies and has no direct impact on the stock price or shareholder value. It simply confirms the smooth functioning of share dematerialization processes during the quarter.